Recent advances in nano vehicles encapsulating cinnamic acid and its derivatives as promising anticancer agents

Area of Science:

• Natural Product Chemistry
• Nanotechnology
• Oncology

Background:

• Despite advances, cancer treatment faces challenges like drug resistance and toxicity.
• Naturally derived compounds, such as cinnamic acid from cinnamon, exhibit antitumor properties.
• Phytochemicals like cinnamic acid often suffer from poor solubility and bioavailability, hindering clinical application.

Purpose of the Study:

• To review recent advancements in nanoformulating cinnamic acid and its derivatives.
• To explore how nanocarriers can overcome the limitations of cinnamic acid for cancer therapy.
• To assess the enhanced therapeutic potential of nanoformulated cinnamic acid in preclinical cancer models.

Main Methods:

• Literature review of recent studies on cinnamic acid nanoformulations.
• Analysis of various nanocarrier systems used for cinnamic acid delivery.
• Evaluation of in vitro and in vivo data on the efficacy and safety of nanoformulated cinnamic acid.

Main Results:

• Various nanocarrier systems, including nanoparticles, liposomes, and micelles, have been developed for cinnamic acid.
• Nanoformulation significantly improves the solubility, bioavailability, and pharmacokinetic profile of cinnamic acid.
• In vitro and in vivo studies demonstrate enhanced anticancer activity and reduced toxicity of nanoformulated cinnamic acid compared to the free drug.

Conclusions:

• Nanoformulation is a promising strategy to enhance the clinical utility of cinnamic acid as an anticancer agent.
• Nanocarriers effectively address the delivery challenges associated with cinnamic acid, improving its therapeutic index.
• Further research into optimized nanoformulations could lead to novel and safer cancer therapies.